Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma
Amir A. Jazaeri(The University of Texas MD Anderson Cancer Center), Edison T. Liu(Jackson Laboratory), David M. Gershenson(The University of Texas MD Anderson Cancer Center), Rosemarie Schmandt(The University of Texas MD Anderson Cancer Center), Christos Sotiriou(Université Libre de Bruxelles), Karen H. Lu(The University of Texas MD Anderson Cancer Center), Gadisetti V.R. Chandramouli(National Institutes of Health), Charles P. Harris(Baylor College of Medicine), Pulivarthi H. Rao(Baylor College of Medicine)
Cited by 90
Related Papers
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k
Clonally Derived Human Embryonic Stem Cell Lines Maintain Pluripotency and Proliferative Potential for Prolonged Periods of Culture
|Developmental Biology|2000|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k